For
basic understanding of transistor properties of doped organic
semiconductors, 3,3′,5,5′-tetramethylbenzidine charge-transfer
complexes are investigated, which change from neutral to ionic by
varying the acceptors. When going into the ionic state, the bulk conduction
increases more rapidly than the mobility, but sufficiently thin devices
exhibit transistor properties. The resulting ambipolar characteristics
are analyzed in the linear regions at small drain voltages in analogy
with graphene transistors. The model is further extended to include
partial overlap of electron and hole transport regions. In the temperature
dependence, the activation energy loses gate voltage dependence when
the neutral–ionic transition takes place by 0.1–0.2
eV above the equal acceptor and donor levels; the difference comes
from the typical trap (polaron) depth or the Madelung energy.
Recently,
dimethylbenzoimidazole (DMBIH) derivatives have attracted
considerable attention as an n-channel dopant. Crystal structures
and conducting properties of several aryl-substituted benzoimidazolium
(DMBI) salts of fluorinated tetracyanoquinodimethanes (F
n
TCNQ, n = 0, 2, and 4) are investigated.
The aryl-groups are not coplanar to the benzoimidazolium part, while
the 1:1 complexes form mixed stacks and show a resistivity as high
as 107 Ω cm. The 2:3 and 1:2 salts have segregate
stacks of TCNQ trimer and tetramer, respectively, and show a comparatively
small resistivity of 102–103 Ω
cm. The DMBI complexes exhibit a large variety of compositions, crystal
structures, and conducting properties, but DMBI tends to induce significant
local structural distortion, which may be an origin of the conductivity
drop upon overdoping.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.